...an interactive and dynamic medical education meeting developed and delivered by international experts to educate on recent advances in haematological oncology
35 DAYS TO GO
This October, AbbVie will be embarking on a new journey with ECHO, AbbVie’s first standalone medical education meeting in the haematology space, at the Hyatt Regency Étoile, Paris, France, on 18–19 October 2019.
Click here to hear about ECHO and the clinical need it addresses from our leadership team.
ECHO’sVISION
Educate on the latest advances in disease biology and the current treatment landscape
Explore and educate on current management trends shaping clinical practice in haematology
Share best practices across haematological malignancies aiming to optimise patient outcomes
ECHO’sUNIQUE APPROACH
Showcase AbbVie’s commitment to advancing patient outcomes
Support the medical community to address growing educational needs in a rapidly evolving treatment landscape
Bring together an esteemed faculty of 18 leading experts and 150+ practising HCPs from around the globe
With ECHO, we are pioneers, demonstrating our passion and commitment to advancing research and development in haematology with an aim to transform standards of care. We are showcasing our leadership in a community with one goal: to improve outcomes for patients with haematological malignancies
ECHO is an exciting initiative bringing together disease experts, haematologists, and industry. It’s an opportunity for us all to share, learn and empower physicians to make the best treatment decisions for their patients
Please contact Kim Chulindra or ECHO2019@lucid-uk.com if you would like more information about ECHO
Kind regards,
Ahmed Kotb
VP – GMA, Oncology
This educational programme is organised and sponsored by AbbVie Medical Affairs
